Novartis - Statistics & Facts
Key insights
- Largest pharma company by total revenue worldwide
- J&J
Detailed statistics
Global leading pharma and biotech companies by total revenue in 2017
- Largest pharma company by Rx pharma revenue worldwide in 2022
- Pfizer
Detailed statistics
Top global pharmaceutical companies based on pharma revenue 2022
- Novartis' market cap as of March 2024
- 233bn USD
Detailed statistics
Top 10 biotech and pharmaceutical companies based on market cap 2024
Company Insights Top 100 health & pharmaceutical companies
Add-OnTop 100 health & pharmaceutical companies
Editor’s Picks Current statistics on this topic
Current statistics on this topic
Related topics
Recommended statistics
Overview
6
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2023
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
- Premium Statistic Top 10 biotech and pharmaceutical companies based on market cap 2024
- Basic Statistic Gross margin ranking of top pharmaceutical companies 2022
- Premium Statistic Pharmaceutical companies - revenue from top 3 products 2022
- Premium Statistic Top therapy classes by spending global market 2027 forecast
Overview
-
Premium Statistic
Pharmaceutical market: worldwide revenue 2001-2023
Pharmaceutical market: worldwide revenue 2001-2023
Revenue of the worldwide pharmaceutical market from 2001 to 2023 (in billion U.S. dollars)
-
Premium Statistic
Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
Leading 50 global pharmaceutical companies by prescription sales and R&D spending in 2022 (in billion U.S. dollars)
-
Premium Statistic
Top 10 biotech and pharmaceutical companies based on market cap 2024
Top 10 biotech and pharmaceutical companies based on market cap 2024
Leading 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2024 (in billion U.S. dollars)
-
Basic Statistic
Gross margin ranking of top pharmaceutical companies 2022
Gross margin ranking of top pharmaceutical companies 2022
Gross margin of the global top pharmaceutical companies in 2022
-
Premium Statistic
Pharmaceutical companies - revenue from top 3 products 2022
Pharmaceutical companies - revenue from top 3 products 2022
Revenue share from major pharmaceutical companies' top 3 products in 2022
-
Premium Statistic
Top therapy classes by spending global market 2027 forecast
Top therapy classes by spending global market 2027 forecast
Projected top therapy areas worldwide in 2027, by spending (in billion U.S. dollars)
Financials
-
Premium Statistic
Novartis' revenue 2007-2023
Novartis' revenue 2007-2023
Novartis AG's total revenue from 2007 to 2023 (in billion U.S. dollars)
-
Premium Statistic
Novartis' revenue by region 2017-2023
Novartis' revenue by region 2017-2023
Novartis AG's revenue from 2017 to 2023, by region (in million U.S. dollars)
-
Basic Statistic
Novartis' net income 2007-2023
Novartis' net income 2007-2023
Novartis AG's net income from 2007 to 2023 (in billion U.S. dollars)
-
Basic Statistic
Novartis' total assets 2015-2023
Novartis' total assets 2015-2023
Novartis AG's total assets from 2015 to 2023 (in billion U.S. dollars)
-
Premium Statistic
Novartis' expenses by type 2018-2023
Novartis' expenses by type 2018-2023
Novartis AG's expenses from 2018 to 2023, by type (in billion U.S. dollars)
Segments
-
Premium Statistic
Novartis revenue 2014-2023 by segment
Novartis revenue 2014-2023 by segment
Novartis AG's revenue from 2014 to 2023, by segment (in billion U.S. dollars)
-
Basic Statistic
Novartis - revenue by market 2023
Novartis - revenue by market 2023
Percentage of Novartis AG's revenue in 2023, by market
-
Basic Statistic
Percentage of Novartis pharmaceuticals revenue by therapy area 2023
Percentage of Novartis pharmaceuticals revenue by therapy area 2023
Percentage of Novartis AG's pharmaceuticals revenue by therapy area in 2023
-
Premium Statistic
Novartis' top drugs based on revenue 2023
Novartis' top drugs based on revenue 2023
Novartis AG's top 10 drugs based on revenue in 2023 (in million U.S. dollars)
Competitors
6
- Basic Statistic Projected top pharmaceutical companies based on sales 2023
- Premium Statistic Pfizer's total revenue 2006-2023
- Premium Statistic Merck & Co - total revenue 2006-2023
- Premium Statistic Johnson & Johnson's total sales 2005-2023
- Basic Statistic AbbVie's revenue 2010-2023
- Premium Statistic Roche Group's total sales 2006-2023
Competitors
-
Basic Statistic
Projected top pharmaceutical companies based on sales 2023
Projected top pharmaceutical companies based on sales 2023
Leading pharmaceutical companies worldwide based on projected 2023 sales (in billion U.S. dollars)
-
Premium Statistic
Pfizer's total revenue 2006-2023
Pfizer's total revenue 2006-2023
Pfizer's total revenue from 2006 to 2023 (in million U.S. dollars)
-
Premium Statistic
Merck & Co - total revenue 2006-2023
Merck & Co - total revenue 2006-2023
Total revenue of Merck & Co. from 2006 to 2023 (in million U.S. dollars)
-
Premium Statistic
Johnson & Johnson's total sales 2005-2023
Johnson & Johnson's total sales 2005-2023
Johnson & Johnson's total sales from 2005 to 2023 (in million U.S. dollars)
-
Basic Statistic
AbbVie's revenue 2010-2023
AbbVie's revenue 2010-2023
AbbVie's revenue from 2010 and 2023 (in million U.S. dollars)
-
Premium Statistic
Roche Group's total sales 2006-2023
Roche Group's total sales 2006-2023
Total sales of the Roche Group from 2006 to 2023 (in million Swiss francs)
Research and development
4
- Premium Statistic Total global pharmaceutical R&D spending 2014-2028
- Premium Statistic Novartis' expenditure on research and development 2004-2023
- Premium Statistic Novartis' R&D expenditure as a percent of revenue 2004-2023
- Premium Statistic Top pharma companies worldwide 2023, by size of R&D pipeline
Research and development
-
Premium Statistic
Total global pharmaceutical R&D spending 2014-2028
Total global pharmaceutical R&D spending 2014-2028
Total global spending on pharmaceutical research and development from 2014 to 2028 (in billion U.S. dollars)
-
Premium Statistic
Novartis' expenditure on research and development 2004-2023
Novartis' expenditure on research and development 2004-2023
Novartis AG's expenditure on research and development from 2004 to 2023 (in billion U.S. dollars)
-
Premium Statistic
Novartis' R&D expenditure as a percent of revenue 2004-2023
Novartis' R&D expenditure as a percent of revenue 2004-2023
Novartis AG's R&D expenditure as a percent of revenue from 2004 to 2023
-
Premium Statistic
Top pharma companies worldwide 2023, by size of R&D pipeline
Top pharma companies worldwide 2023, by size of R&D pipeline
Leading 15 pharmaceutical companies worldwide by size of R&D pipeline as of 2023
Outlook
4
- Premium Statistic Sales forecast of select blockbuster drugs by Novartis worldwide 2028
- Basic Statistic Sales forecast of select Novartis R&D projects worldwide 2028
- Premium Statistic Top pharma companies by cardio revenue worldwide 2023 and 2028
- Basic Statistic AI readiness of big pharma companies 2023
Outlook
-
Premium Statistic
Sales forecast of select blockbuster drugs by Novartis worldwide 2028
Sales forecast of select blockbuster drugs by Novartis worldwide 2028
Sales forecast of select Novartis blockbuster drugs worldwide in 2028 (in million U.S. dollars)
-
Basic Statistic
Sales forecast of select Novartis R&D projects worldwide 2028
Sales forecast of select Novartis R&D projects worldwide 2028
Sales forecast of select Novartis R&D projects worldwide in 2028 (in million U.S. dollars)
-
Premium Statistic
Top pharma companies by cardio revenue worldwide 2023 and 2028
Top pharma companies by cardio revenue worldwide 2023 and 2028
Global leading 10 pharmaceutical companies based on cardiovascular revenue in 2023 and a forecast for 2028 (in billion U.S. dollars)
-
Basic Statistic
AI readiness of big pharma companies 2023
AI readiness of big pharma companies 2023
Index of AI readiness of select big pharma companies as of 2023
Further reportsGet the best reports to understand your industry
Get the best reports to understand your industry
Contact
Get in touch with us. We are happy to help.
Meredith Alda
Sales Manager– Contact (United States)
Mon - Fri, 9am - 6pm (EST)
Yolanda Mega
Operations Manager– Contact (Asia)
Mon - Fri, 9am - 5pm (SGT)
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)
Mon - Fri, 10:00am - 6:00pm (JST)
Lodovica Biagi
Director of Operations– Contact (Europe)
Mon - Fri, 9:30am - 5pm (GMT)
Carolina Dulin
Group Director - LATAM– Contact (Latin America)
Mon - Fri, 9am - 6pm (EST)